Home
Home Page
Recent Posts
Top Active Boards
Popular Posts
Biotech Tweets
Market Tweets
Energy Industry Tweets
Official IV Sponsor Page
My Content
My Boards
My Feed
My Library
My Links
Boards Search
Groups Directory
My Network
My Favorite Posters
My Private Message Groups
My Blocked Sender List
Member Directory
Account
Email & Password
Subscription/Membership
All Account Details
My Profile
My Device Info
Sign Up
Settings
My Site Settings
My Notification Settings
BOARDS
Sign In for Filters
|
BOARDS
Become a Member
|
Sign In
Advertise With Us
Board Stats
:
329 members / 2125 guests [742]
Bristol-Myers Squibb Co.
Board
Links
(more...)
Y!
CELG MM R&D deep dive
CELG legacy IV board (still active)
CELG legacy IV board (premium)
@bmsnews (Company Twitter Account)
GoFundMe Mike Barnett Recovery Fund
BMY / Message Board
BOARD
GROUPS
Loading...
Written By
On Topic Only
--
All Messages
Hide Replies
Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
Go to Msg #
MSG #
SUBJECT
TYPE
AUTHOR
SENTIMENT
RECS
DATE POSTED
10138
ABECMA-related Excerpts from BMY's BCMA CAR-T partner 2seventy bio (TSVT) 2Q2022 Earnings Call
GN
JBWIN
6
8/11/2022 2:34:27 PM
10137
Re: Drug pricing —- Medicare negotiations in healthcare bill
GN
teflon2000
1
8/11/2022 11:17:43 AM
10136
Building IP: BMY Patent Application re "CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS"
GN
JBWIN
0
8/11/2022 1:10:42 AM
10135
Building IP: BMY Patent Application re "IMMUNOMODULATORS"
GN
JBWIN
0
8/11/2022 1:08:56 AM
10134
Building IP: BMY Patent Application re "ANTI-CTLA4 ANTIBODY PRODRUGGABLE (PROBODY) AT A CDR POSITION"
GN
JBWIN
0
8/11/2022 1:07:31 AM
10133
Building IP: CELG Patent Application re "AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME"
GN
JBWIN
0
8/11/2022 1:04:56 AM
10132
Building IP: Celgene Quanticel Research Patent Application re "AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME"
GN
JBWIN
0
8/11/2022 1:03:49 AM
10131
Building IP: Celgene CAR LLC Patent Application re "METHODS OF TREATING A MK2-MEDIATED DISORDER"
GN
JBWIN
0
8/11/2022 1:02:11 AM
10130
Building IP: JUNO Patent Applcation re "COMBINATION THERAPY OF A CELL-MEDIATED CYTOTOXIC THERAPY AND AN INHIBITOR OF A PROSURVIVAL BCL2 FAMILY PROTEIN"
GN
JBWIN
0
8/11/2022 1:00:07 AM
10129
Update including Topline Results from Phase 3 KarMMa-3 Trial Showing Abecma (idecabtagene vicleucel) Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma
GN
JBWIN
2
8/10/2022 6:47:29 PM
Go to Msg #
About Us
•
Contact Us
•
Follow Us on Twitter
•
Members Directory
•
Help Center
•
Advertise
•
Official IV Sponsor Page
Become a Patron
© 2003-2022 Investorvillage.com. All rights reserved.
User Agreement
Financial Market Data provided by
.
Loading...